KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Return on Capital Employed (2018 - 2026)

Twist Bioscience has reported Return on Capital Employed over the past 9 years, most recently at 25.84% for Q1 2026.

  • Quarterly Return on Capital Employed rose 1232.0% to 25.84% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 25.84% through Mar 2026, up 1232.0% year-over-year, with the annual reading at 25.39% for FY2025, 998.0% up from the prior year.
  • Return on Capital Employed was 25.84% for Q1 2026 at Twist Bioscience, down from 24.04% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 23.98% in Q2 2022 and troughed at 39.77% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 27.7% (2023), against an average of 29.96%.
  • Year-over-year, Return on Capital Employed crashed -987bps in 2024 and then skyrocketed 1506bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 26.23% in 2022, then fell by -21bps to 31.84% in 2023, then decreased by -21bps to 38.48% in 2024, then soared by 38bps to 24.04% in 2025, then dropped by -7bps to 25.84% in 2026.
  • Per Business Quant, the three most recent readings for TWST's Return on Capital Employed are 25.84% (Q1 2026), 24.04% (Q4 2025), and 24.71% (Q3 2025).